Wednesday, December 7, 2011

Bone Marrow Transplantation - Table of Contents alert Volume 46 Issue 12

TABLE OF CONTENTS

Volume 46, Issue 12 (December 2011)

In this issue
Review
Original Articles
Letters to the Editor
Book Review

Also new
AOP

Advertisement


The CliniMACS® Cell Separation System, based on MACS® Technology, enables the operator to perform clinical-scale magnetic enrichment of target cells or depletion of unwanted cells.

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
If you are unable to access the articles in this Table of Contents e-alert in full, your library may not subscribe to this journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.

 

Review

Top

The role of the endothelium in the short-term complications of hematopoietic SCT

E Carreras and M Diaz-Ricart

Bone Marrow Transplant 2011 46: 1495-1502; advance online publication, April 4, 2011; 10.1038/bmt.2011.65

Abstract | Full Text

Original Articles

Top

CONDITIONING REGIMENS

90Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma

K E Abou-Nassar, K E Stevenson, J H Antin, K McDermott, V T Ho, C S Cutler, A S LaCasce, E D Jacobsen, D C Fisher, R J Soiffer, E P Alyea, J Koreth and A S Freedman

Bone Marrow Transplant 2011 46: 1503-1509; advance online publication, January 24, 2011; 10.1038/bmt.2010.339

Abstract | Full Text

Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party

J Wachowiak, K-W Sykora, J Cornish, A Chybicka, J R Kowalczyk, E Gorczyńska, M Choma, G Grund and C Peters on behalf of the EBMT Pediatric Diseases Working Party

Bone Marrow Transplant 2011 46: 1510-1518; advance online publication, February 7, 2011; 10.1038/bmt.2010.343

Abstract | Full Text

STEM CELL PROCUREMENT

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

S Malik, B Bolwell, L Rybicki, O Copelan, H Duong, R Dean, R Sobecks, M Kalaycio, J Sweetenham, B Pohlman, S Andresen, S Tench, A Koo, P Figueroa and E Copelan

Bone Marrow Transplant 2011 46: 1519-1525; advance online publication, January 24, 2011; 10.1038/bmt.2010.336

Abstract | Full Text

CORD BLOOD STEM CELLS

Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID

A Iguchi, N Kawamura, R Kobayashi, S-I Takezaki, Y Ohkura, J Inamoto, J Ohshima, M Ichikawa, T Sato, M Kaneda, Y Cho, M Yamada, I Kobayashi and T Ariga

Bone Marrow Transplant 2011 46: 1526-1531; advance online publication, January 24, 2011; 10.1038/bmt.2010.338

Abstract | Full Text

PEDIATRIC TRANSPLANTS

Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT

K P Daly, S D Colan, E D Blume, R Margossian, K Gauvreau, C Duncan, L E Lehmann and M H Chen

Bone Marrow Transplant 2011 46: 1532-1539; advance online publication, January 31, 2011; 10.1038/bmt.2010.345

Abstract | Full Text

ALLOGRAFTING

Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies

W Zinke-Cerwenka, A Valentin, U Posch, C Beham-Schmid, A Groselj-Strele, W Linkesch, A Wölfler and H Sill

Bone Marrow Transplant 2011 46: 1540-1544; advance online publication, August 22, 2011; 10.1038/bmt.2011.165

Abstract | Full Text

MICROBIAL ISSUES

A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality

A Hodson, M Kasliwal, M Streetly, E MacMahon and K Raj

Bone Marrow Transplant 2011 46: 1545-1550; advance online publication, January 24, 2011; 10.1038/bmt.2010.347

Abstract | Full Text

POST-TRANSPLANT EVENTS

Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study

D C L Lam, B Lam, M K Y Wong, C Lu, W Y Au, E W C Tse, A Y H Leung, Y L Kwong, R H S Liang, W K Lam, M S M Ip and A K W Lie

Bone Marrow Transplant 2011 46: 1551-1556; advance online publication, February 14, 2011; 10.1038/bmt.2011.1

Abstract | Full Text

GRAFT-VERSUS-TUMOR EFFECTS

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells

A Meguro, K Ozaki, K Hatanaka, I Oh, K Sudo, T Ohmori, H Matsu, R Tatara, K Sato, Y Sakata, S Nakae, W J Leonard and K Ozawa

Bone Marrow Transplant 2011 46: 1557-1565; advance online publication, January 24, 2011; 10.1038/bmt.2010.342

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

Expression of CD64 (FcγRI) in skin of patients with acute GVHD

A van Royen-Kerkhof, V Walraven, E A M Sanders, R de Weger, D F van Wichen, E de Koning, T Thepen, J G J van de Winkel and J H W Leusen

Bone Marrow Transplant 2011 46: 1566-1569; advance online publication, January 17, 2011; 10.1038/bmt.2010.337

Abstract | Full Text

Letters to the Editor

Top

Inherent problems of comparing second and third remission in patients with acute lymphoblastic leukemia

D K L Cheuk

Bone Marrow Transplant 2011 46: 1570; advance online publication, January 17, 2011; 10.1038/bmt.2010.333

Full Text

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes for children with B-precursor ALL and early or late BM relapse

M J Burke, M R Verneris and J C Beck

Bone Marrow Transplant 2011 46: 1571-1572; advance online publication, January 17, 2011; 10.1038/bmt.2010.334

Full Text

Low-dose trimethoprim–sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT

T Muto, M Takeuchi, T Kawaguchi, S Tanaka, S Tsukamoto, S Sakai, Y Takeda, D Abe, C Ohwada, E Sakaida, N Shimizu, K Yokote, T Iseki and C Nakaseko

Bone Marrow Transplant 2011 46: 1573-1575; advance online publication, January 17, 2011; 10.1038/bmt.2010.335

Full Text

Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL

D Tseng, C D Jones, M Anderson, R Warnke, J L Zehnder and D B Miklos

Bone Marrow Transplant 2011 46: 1576-1578; advance online publication, January 24, 2011; 10.1038/bmt.2010.340

Full Text

Alemtuzumab as salvage therapy for steroid and ATG/etanercept-refractory acute GVHD

K Jackson, C Curley, J Leach, A McLean, M Nakagaki, S Durrant and G A Kennedy

Bone Marrow Transplant 2011 46: 1579-1580; advance online publication, January 24, 2011; 10.1038/bmt.2010.341

Full Text

Successful hematopoietic SCT from non-identical twins to two sisters with β-thalassemia major by using preimplantation genetic diagnosis and HLA typing

M A Yesilipek, G Karasu, N Erçelen, V Uygun, M Akcan, A Kupesiz and V Hazar

Bone Marrow Transplant 2011 46: 1581-1582; advance online publication, January 17, 2011; 10.1038/bmt.2010.344

Full Text

Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT

T Kawaguchi, S Tsukamoto, C Ohwada, M Takeuchi, T Muto, S Tanaka, S Sakai, Y Takeda, D Abe, E Sakaida, N Shimizu, K Yokote, T Iseki, K-I Imadome and C Nakaseko

Bone Marrow Transplant 2011 46: 1583-1585; advance online publication, January 31, 2011; 10.1038/bmt.2010.346

Full Text

Combining allografting with mTOR inhibitors for metastatic renal cell cancer

M Bregni, G Vitali and J Peccatori

Bone Marrow Transplant 2011 46: 1586; advance online publication, February 7, 2011; 10.1038/bmt.2011.6

Full Text

Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT

C Calmettes, S Vigouroux, R Tabrizi and N Milpied

Bone Marrow Transplant 2011 46: 1587-1589; advance online publication, September 19, 2011; 10.1038/bmt.2011.179

Full Text

Book Review

Top

Blood and marrow transplant handbook: comprehensive guide for patient care

M H Gilleece

Bone Marrow Transplant 2011 46: 1590; 10.1038/bmt.2011.200

Full Text

Advertisement
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: